Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Molnupiravir, first developed for hepatitis C, might be able to prevent or treat COVID-19 outside of a clinical setting.
The COVID-19 pandemic has profoundly disrupted almost every aspect of the battle against HIV.
This funding will help strengthen vaccine confidence and access, as well as COVID-19 testing and treatment, in communities of color.
The actors help debunk COVID-19 vaccine misconceptions in a new bilingual campaign.
Vaccine hesitancy among racial and ethnic minorities has faded, and confidence in vaccines is growing even among Republicans.
Along with exacerbating existing health problems, the COVID-19 pandemic has also caused a host of new medical issues in patients.
Cancer, diabetes and Alzheimer’s would be the initial focus for the proposed agency within the National Institutes of Health.
Many experts argue that COVID-19 cannot be curbed without vaccinating children. But others aren’t so sure.
People with immune deficiency may not respond as well to vaccines but could still gain some protection.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.